29 research outputs found

    Wir überwachen uns. Wie die Sicherheit durch die Digitalisierung immer tiefer in den Alltag eingreift und warum uns das nicht interessiert

    Get PDF
    Der Bereich der Überwachung und Sicherheit unterliegt einer neoliberalen Neuausrichtung. Mit der Entstehung unheiliger Allianzen zwischen Staat und Wirtschaft, gezielter Privatisierung und einer neuen Warenförmigkeit von Sicherheit entgrenzen sich zunehmend auch deren Produktionsprozesse. Das Subjekt wird durch eine Digitalisierung der Alltagswelten zunehmend in die Sicherheitsarbeit mit eingebunden und übernimmt zentrale Aufgaben. Der Mensch, ohne dessen Zutun das digitale Überwachungssystem nicht so gut funktionieren würde, erscheint außerstande und unwillig, sich dieser Entwicklung zu entziehen

    Digitale Stadtplanung: Alltag und Räume technisierten Planens

    Get PDF
    Was bedeutet Digitalisierung in der Planung, wie verändern sich dadurch das Planen und der Blick auf Städte? In einer vergleichenden ethnografischen Studie untersucht der Autor aus einer raumsoziologischen Perspektive die Arbeitswelten von Stadtplaner*innen im Umgang mit digitalen Technologien. Dabei zeigt er, wie die Nutzung dieser Werkzeuge mit dem Tun der Planer*innen, der Organisation von Planungsprozessen und der Weise, wie Raumwissen konstruiert wird, zusammenhängen. Digitalisierung versteht sich so als technisiertes räumliches Anordnen sozialer Beziehungen. Sie materialisiert sich in den Orten des Planens und darin, wie Planer*innen Städte und Räume sehen, verstehen und gestalten

    Digitale Stadtplanung

    Get PDF

    Cartilage regeneration using zonal chondrocyte subpopulations: a promising approach or an overcomplicated strategy?

    Get PDF
    Cartilage defects heal imperfectly and osteoarthritic changes develop frequently as a result. Although the existence of specific behaviours of chondrocytes derived from various depth-related zones in vitro has been known for over 20 years, only a relatively small body of in vitro studies has been performed with zonal chondrocytes and current clinical treatment strategies do not reflect these native depth-dependent (zonal) differences. This is surprising since mimicking the zonal organization of articular cartilage in neo-tissue by the use of zonal chondrocyte subpopulations could enhance the functionality of the graft. Although some research groups including our own have made considerable progress in tailoring culture conditions using specific growth factors and biomechanical loading protocols, we conclude that an optimal regime has not yet been determined. Other unmet challenges include the lack of specific zonal cell sorting protocols and limited amounts of cells harvested per zone. As a result, the engineering of functional tissue has not yet been realized and no long-term in vivo studies using zonal chondrocytes have been described. This paper critically reviews the research performed to date and outlines our view of the potential future significance of zonal chondrocyte populations in regenerative approaches for the treatment of cartilage defects. Secondly, we briefly discuss the capabilities of additive manufacturing technologies that can not only create patient-specific grafts directly from medical imaging data sets but could also more accurately reproduce the complex 3D zonal extracellular matrix architecture using techniques such as hydrogel-based cell printing

    High Anti-CoV2S Antibody Levels at Hospitalization Are Associated with Improved Survival in Patients with COVID-19 Vaccine Breakthrough Infection

    No full text
    Background: Although vaccination against COVID-19 is highly effective, breakthrough infections occur, often leading to severe courses and death. The extent of protection provided by individual antibody levels in breakthrough infections is still unknown and cut-off levels have yet to be determined. Methods: In 80 consecutive fully vaccinated patients hospitalized between August and December 2021 with COVID-19 breakthrough infection (Delta variant), anti-CoV2S antibody levels were analyzed for the endpoint of death. Results: Ten out of the 12 patients who died (83.3%) had antibody levels 600 U/mL died from vaccine breakthrough infection. Correction for the number of comorbidities and age revealed that anti-CoV2S antibody levels at the time of hospitalization were a significant predictor for reduced risk of death (OR = 0.402 for every 1000 U/mL, p = 0.018). Conclusions: In this retrospective data analysis, we show that almost all patients who died from COVID-19 vaccine breakthrough infection had antibody levels < 600 U/mL, most of them below 200 U/mL. In logistic regression corrected for the number of comorbidities and age, anti-CoV2S antibody levels at the time of hospitalization proved to be a significantly protective predictor against death
    corecore